Select Committee on Health Minutes of Evidence


Examination of Witnesses (Questions 120-139)

MR IVAN LEWIS MP, MR NICK CHAPMAN, PROFESSOR SUE HILL AND MS HELEN MACCARTHY

8 MARCH 2007

  Q120  Chairman: It is the case, is it, that currently, because of the excessive waiting times in areas, because a lot of hearing problems are in the elderly and it is something that deteriorates, that somebody will have an initial test at a cost to the British taxpayer, who then, because they have to wait a length of time, will have to have that same test again before anything can be done? It seems to me that to organise a system or for a system to be allowed to be run like that is enormously expensive to the taxpayer.

  Mr Lewis: It is completely unacceptable and, based on the best practice in the best areas, unnecessary.

  Q121  Sandra Gidley: I struggle with this 18 weeks. In the Department's submission it says it would not be appropriate for people who are directly referred to be covered by 18 weeks. I am sure the many thousands of people who are referred direct to audiology services cannot actually appreciate the difference. It is semantics as far as they are concerned. Why is it not appropriate for direct referrals to be treated in the same way, with the same targets, as those who are going via an ENT surgeon? Are you not actually putting in a perverse incentive for people to inappropriately refer?

  Mr Lewis: The point is that before the publication of this framework and this clear new policy framework for the way audiology needs to be done in the NHS, that perverse incentive was absolutely at the core of the potential problem, that because those referred directly to ENT would be covered by the 18 week target and others would not, the system would say we might as well refer directly to ENT because that is the way were going to get our patient the quickest treatment in the most effective way. I believe the publication of the framework this week, this new policy for audiology in the NHS, will actually put an end to the danger of that unintended consequence. In answer to your question, there is only one answer I can give you because it is a straight answer. There were a number of things excluded from the 18-week target when the judgement was made about what treatments and the definition that ought to fall within the 18 weeks and this was one of them. If you then go back to the NHS and say, "Having looked at this, we are going to include this category of patients. Having reconsidered it, we're going to include another category patients," before you know where you are, you are essentially destabilising the system. That is the answer, but I genuinely believe and the expectation that has been made very clear to the NHS is, it has to be acknowledged—and this is not a new announcement; this has been an expectation that the NHS has had since 2005 that the maximum six weeks for assessment everywhere for everybody, whatever the nature of referral, which they have known about since 2005. Our point is—and I have these sheets to hand round later which explains the modern technology—if you look at the modern technology, as I say, there is absolutely no excuse, once you are able to achieve a maximum six-week wait for assessment, that you cannot then move to get the digital hearing aid fitted either immediately or very soon after.

  Q122  Sandra Gidley: You said 50% could be done on the same day but in the short term, if there is a political imperative to do the diagnostics within six weeks, are you not creating another unintended consequence, where all of the effort is put into hitting the target and people just have to wait; despite the fact that it can be done, the time constraints mean that it will not be done and people end up having to wait longer for a fitting if we are not careful. What is being done to prevent that happening?

  Mr Lewis: What is being done is that the Department, the Strategic Health Authorities, and the PCTs are making absolutely clear that that would be entirely unacceptable and that audiology has been elevated this week to one of the NHS's priorities. If you want me to be very frank, I suspect that until very recently audiology was not seen as one of the NHS's top priorities. So every SHA and every PCT now understands that there will be accountability, there will be transparency, there will be performance management and there are the resources in the system—let us be clear about that—to enable them to slash waiting lists and waiting times. The proof of the pudding will be in the eating.

  Q123  Sandra Gidley: You said there were the resources in July of last year. On 25 July Lord Warner said 300,000 new service areas for assessment fittings and follow-ups would be provided. You have just alluded to that. Nothing has happened since July. When is it going to happen?

  Mr Lewis: It is going to happen... Sorry.

  Chairman: You have just jumped down the agenda by about six questions.

  Sandra Gidley: I am sorry. You can answer it later.

  Q124  Dr Stoate: I think you have a Herculean task on your plate. You said you believed the capacity exists to make a big difference but we have heard this morning from the RNID that the NHS does approximately half a million fittings a year. There were approximately half a million people currently waiting, in other words there is a year's worth of work currently in the system where people are waiting for a fitting. We also heard that there is potentially 6.5 million people in this country who actually suffer hearing loss sufficient to require a hearing aid should they make themselves available to have one fitted. In other words, the task is immense. I am very concerned that you seem to think that the NHS can somehow cope with all this within existing resources when we are hearing from lots of people, including witnesses, including in written submissions, and including the previous people we talked to this morning, that that is pretty unrealistic. How do you think you are going to achieve it?

  Mr Lewis: I think we have demonstrated in areas where they work in an integrated way in terms of the different professionals that are involved in responding to this problem. We have slashed the cost of the whole process from referral through to fitting in an amazing way, from thousands of pounds to, I think, an overall cost of £260 for the entire process. We have already put significant amounts of resources into the system for this purpose. I really have to link Howard's question to Sandra's question. The reason that we have not yet proceeded with the tendering is because what the shareholders and the PCTs are saying to us is "We want to be absolutely certain that the amount of pathways you tender for are necessary because we do not believe that at the moment we are getting maximum use out of our existing capacity." That is linked to this as well. But you are right. Howard makes the point, and you did, Kevin, that demographic factors are a reality in this area of policy as they are for the rest of the NHS and indeed for social care. People are living longer and longer, they have more more complex conditions, disabled people are these days having fuller lives, all of which is a good sign in terms of the kind of society we want to live in, but that does place new questions on the NHS, on social care, on public policy generally, that we need to reflect on and we need to ensure that we have a system that can genuinely respond to those demographic pressures and those demographic realities. I cannot today say to Howard and any other member of this Committee that it is not a challenge, because it is a challenge but what I am trying to say is that the levers and incentives and accountability that we have now put into the system, and the capacity that is available, we believe will lead to the slashing of waiting lists and waiting times for audiology in the NHS in every part of the country, which will also lead to greater equity. The inequity in terms of waiting times and waiting lists depending on where you live in relation to audiology cannot be acceptable, nor is it consistent with the NHS's values.

  Q125  Dr Stoate: The worry is that you are setting yourself up for a fall, and the reason I say that is because currently GPs can use the system either by referring direct to ENT to get into the 18-week target or to audiology if they feel that audiology is working in their area. I do not yet see what disincentivises GPs from doing that. I know your aspiration is for a six-week audiology assessment and, hopefully, a one-stop fitting, and that would be wonderful if it happened but in areas where, let us be honest, that is not going to happen, at least, not very quickly, GPs are simply going to say, "We will have to go down the ENT route because that way I can at least guarantee my patients a fair service" and you will not get GPs simply trying to play fair, if you like, by what you are trying to do, because they will see in their patient's interest which way to go.

  Mr Lewis: I have a much higher opinion of your colleagues than you do, Howard.

  Q126  Dr Stoate: They are fighting for their patients and their patients will get a better deal if they go the 18-week route.

  Mr Lewis: One of the things that is clear is where there is a good relationship between GPs, between primary care and audiology departments and ENT within acute hospitals, the quality of the service, the nature of the response, the waiting lists and waiting times are in much better shape. So one of the challenges for PCTs particularly is to ensure that not just they look at this as hitting a target but that they reorganise the nature of their service and the contribution of the respective professionals to ensure that in each locality they have a sensible system, but the consequence of everybody's intervention is significantly reduced waiting lists and waiting times for patients. I am an optimist; maybe you are less optimistic. That is the nature of politics. The other point I want to make today is I personally and the Department along with the RNID will be monitoring progress. We will not simply be publishing this document this week, appearing before the Select Committee and then moving on to the next agenda item. We will have to monitor progress on an ongoing basis to make sure the system is shifting, and shifting quickly on this issue.

  Q127  Dr Stoate: The problem with optimism is that the definition of optimism is it is someone who has not heard the bad news yet. That is the difficulty.

  Mr Lewis: I am a Manchester City supporter, Howard. I do know the bad news.

  Q128  Dr Stoate: Clearly, one of the ways we are going to achieve this target hopefully is through a better skill mix. We have talked to witnesses before about improving skill mix. Why has that not happened yet? Why do we have to have this inquiry? Why has the skill mix not already been sorted out to try and increase capacity? Why are you talking about aspiring to improving capacity? If you can improve capacity, why have you not done so?

  Mr Lewis: I can only take responsibility for the period for which I have been responsible but the reality is I do not think the NHS and in fact, to be fair to the NHS, the Department or our partners in the voluntary sector anticipated the explosion in demand as a consequence of the modernisation project. The explosion of demand has implications for resources, it has implications for waiting times and for patients. It also has major implications in terms of work force. To be fair though, if you look at the commissioned number of places in training, for example, for audiologists, there has been a significant year-on-year increase. You may want to ask me some questions about this but in terms of the number of training places that have been created now and will be coming through over the next few years, because obviously, as you know, the time lag between training, qualifying and being fit to practise is significant. We only started really investing in significant new audiology training places in a relatively recent period of time and the first graduates are coming out around now. So let us be clear. Audiology, I guess, was not one of the NHS's most important services, and that is reflected across the board; it could be regarded as a Cinderella service. In my view, the inability to hear properly is about people's quality of life. It is about their ability every day to function in their family, in their community, in their place of work, in society. It is massively important. It is not a minor issue. That is why I would say to you, all I can say is yes, clearly, it would be a nonsense for me to sit here today and say things could not have been done better and could not have been planned more effectively over a period of time. It would be a nonsense for me to say that, but my job now is to address the failings and weaknesses in the system, recognizing what levers I have to pull in a ministerial position because in the end, we do not want every PCT and every hospital and every doctor's surgery in the country—we need to be clear about that—but we do have a duty to put in place the levers, the incentives, the accountability framework to make sure that people with hearing impairments get the service that they deserve from the NHS, which in some parts of the country they are currently being denied.

  Q129  Dr Stoate: That is certainly very encouraging. So what you are really saying now is you are honestly able to say that audiology services are now a much higher priority in the NHS than they previously were?

  Mr Lewis: The judgement I would make about that is, would a chief executive in an SHA or a PCT regard their responsibilities on audiology to be one of the things that they need to be keeping a very regular close eye on? That is how I would define my answer to your question, as well as the ability then to engage with the professionals on the front line, to get the professionals to work together, to believe the commitment is real, they will have the resources and we can make it happen. If that is the question, the answer is yes.

  Q130  Chairman: We will wait with interest to see how this best practice spreads throughout that particular part of the National Health Service over the next few years, Minister. Could I just say, because it is not specific in the report but we have had evidence which will be published next week on the website, from the National Deaf Children's Society. Do you look at the issue of school-age children and waiting times differently to the general customer? It is normally obviously demographics that determine the need.

  Mr Lewis: I have to be honest with you. I think we do look at it differently because the basis of the data I have for the Committee on this is minimal. So it is clear to me that we do not have anywhere near as much hard data on this issue as we could or maybe should have and we need to review that as a consequence of this process. What I will say to you, Kevin, is two things. First of all, the fact that we now test newborn babies in terms of hearing is a fantastic step forward and, as a result of that, we are able to get in really early with thousands of babies and prevent a deterioration which could end up in a far worse situation. I also believe anecdotally, by speaking to professionals on the front line, that even now, with the difficulties, in practically every health economy children with hearing problems are prioritised in the vast majority of cases. On the other hand, the caveat is I do not have as much hard data as I would like to give you cast-iron guarantees.

  Chairman: It is just the issue that denying somebody of my age to hear better is a lot different to denying a five-year-old the ability to be educated like all their peers.

  Q131  Dr Naysmith: Good morning, Minister. Welcome back to the Committee. I hope you are enjoying it as much as you used to enjoy it when you sat here!

  Mr Lewis: I am waiting for David to speak before I can answer that.

  Q132  Dr Naysmith: We are saving him till last today. Obviously, all the things you have been planning and announcing this week, you are not going to be able to manage to do it without the private sector, I suspect. We have had some experience of collaboration between commercial firms and the National Health Service and the so-called public-private partnership. Do you think it has been a success?

  Mr Lewis: In this area? Overall, frankly, the modernisation programme, we spent £125 million, did in the end benefit three quarters of a million people. I think it is fair to say that those people regard that as a success and that the private sector's engagement with that really was significant and we would not have been able to do it without them. I also believe that, in terms of our ambitious programme to get the situation under control within a relatively short period of time, we will need to be able and willing to work in partnership in a sensible way with the private sector. I would say to you, Doug, that if you look at the national framework that was set out in terms of working with the private sector, it also meant we were able to get incredibly good value compared to how much we were paying previously. I know there have been one or two exceptions to this, and I will try and explain why, because some local NHS organisations have gone out and worked with the independent sector separately to the national framework that we have actually created and set out. Wherever that national framework has been used by the local NHS, the economies of scale, the efficiency of outcome is indisputable. Where some local NHS organisations have decided to engage with the independent sector themselves, I am afraid to say they have got a far worse deal off them, it has cost a lot more money and the outcome has not always been as good for patients as it should have been.

  Q133  Dr Naysmith: We heard that this morning from the private sector representative very clearly. He said he did not recognize the criticisms that I am going to put to you now but we have had evidence, which unfortunately has not yet been published but it will be next week, witnesses saying that the costs to the National Health Service by using the private sector were twice the costs of doing things under the National Health Service, and that there were cases of work being paid for and not being done, because the patients were not supplied—that brings memories of things that have happened elsewhere in the system—and also that there were needs for re-referrals and so on that were not part of the initial contract. We need to wait and see exactly whether we are talking about the sorts of things you were saying, ad hoc arrangements and not under the contract, but we need to be sure that these contracts are properly tied up, do we not?

  Mr Lewis: We do. I would say to you that variability in performance in this area is not necessarily about public or private, and I think there are arguments to be had in other areas of public-private sector partnerships where there has been shoddy performance, etc, where you might say part of the problem is the private sector is new to it, they do not have the capacity, they do not have the expertise, and they do not invest the resources. In this area I think it would only be fair for me to say that I think a lot of the variability in performance is not about whether it is public or private.

  Q134  Dr Naysmith: I wonder if I could ask Ms MacCarthy, because we have heard that you had some concerns in the supply Purchasing and Supply Agency about the public-private partnership. Is that true?

  Ms MacCarthy: No. We have not had any negative feedback at all to suggest that the public-private partnership that we put in place at the national framework level that the Minister has described about the performance that has been provided, which is why we were saying earlier that there are instances where those private partnerships exist outside of that framework and we therefore encourage that governance comes back under the framework and we have that kind of control and monitoring and governance in place to make sure that those sorts of things do not happen.

  Q135  Dr Naysmith: Were these ad hoc arrangements encouraged by the Department but not overseen by the Department, the ones that were not part of the public-private partnership?

  Mr Lewis: I would not imagine so. I can write you on that.[1] I cannot be definitive. I think what we would encourage is for people to use the benefits of us having done a tremendous amount of work nationally to get this guidance or framework right to say to the local NHS use that, because that has delivered. It can demonstrate how you get quality outcomes but equally, it demonstrates how you can get amazing value for money compared to what has been done previously. I would not imagine we have ever been in a position where we have been encouraging them to do their own deals with the private sector outside that framework, no. It would not make sense. The only other point, obviously, if somebody, for example, gets an assessment on the NHS and then is so frustrated and is waiting and then chooses clearly to purchase the rest of the service in the market, the costs can be excessive. There is no doubt about that. That is clear, is it not? If you look at where this is done outside of the NHS, where it is not about the NHS commissioning from the private sector, people can end up paying an awful lot of money.

  Q136 Mr Campbell: The Hearing Aid Council has stated that the regulatory framework for dispensing hearing aids was not fit for purpose.

  Mr Lewis: Was this recent?

  Q137 Mr Campbell: I believe it would be recent because they are going to be abolished shortly, are they not?

  Professor Hill: The Hampton review has been reviewing a number of arm's-length bodies sponsored by the Department of Trade and Industry and the Hearing Aid Council is one of those. The Hearing Aid Council has been looking at ways in which private sector hearing aid audiologists will be trained in future, and indeed, in partnership with higher education institutes, they are introducing from this year a new foundation degree.

  Q138  Mr Campbell: It says here " ... unregulated professionals, coupled with a lack of common standards of education" of these people. Is this sour grapes on their part? I know there are going to be abolished, but why should they say "not fit for purpose"?

  Mr Lewis: All I can say is that obviously, we believe that the regulatory framework that is in place is appropriate to secure protection, minimum protection, for patients and to ensure that we support best professional practice. We are not going to sit here and say as far as we are concerned the regulatory framework is flawed. That organisation is probably going through a period of change, from what I gather, and they may genuinely be concerned about what that change is going to mean in terms of protection, and I think they are entitled to say that if that is how they feel, but we are certainly not, in my view, leaving the system so unregulated that we are putting patients at risk of a poor service.

  Q139  Mr Campbell: I am beginning to wonder, if it is, could this affect the running of the PPP?

  Mr Lewis: There is a whole series of things that will affect it. Obviously, regulation is a very important factor in ensuring standards, protecting patients and making sure that there is accountability.


1   Ev 125 Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2007
Prepared 16 May 2007